|
Home : Unsafe Drugs : Avandia : News Articles : GlaxoSmithKline to take $3.4 bln charge on Avandia - Forbes.com GlaxoSmithKline to take $3.4 bln charge on Avandia - Forbes.com
will take a 2.2 billion pounds ($3.4 billion) charge against earnings in the fourth quarter to provide for litigation over its diabetes drug, Avandia. The company said Monday that the charge is mainly due to additional costs related to the investigation of the ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




